Immunohistochemical demonstration of 15-lipoxygenase in transplant coronary artery disease

S. Ravalli, C. C. Marboe, V. D. D'Agati, Robert E. Michler, E. Sigal, P. J. Cannon

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

15-Lipoxygenase (15-LO) catalyzes the oxygenation of arachidonic acid linoleic acids and has been implicated in the oxidative modification of low-density lipoproteins (LDL). 15-LO mRNA and protein have previously been demonstrated in macrophages of rabbit and human atherosclerotic lesions. The purpose of this study was to investigate whether 15-LO is also present in the accelerated form of coronary artery disease that can complicate cardiac transplantation (TCAD). Immunohistochemical analysis of coronary arteries with TCAD was carried out by using a rabbit polyclonal antibody raised against human recombinant 15-LO and an avidin-biotin-immunoperoxidase system. Normal coronary and pulmonary arteries showed no immunostaining for 15-LO. Two different types of TCAD were observed. One type consisted of concentric intimal proliferation of smooth muscle cells, without lipid or calcium deposits. No immunoreactivity for 15-LO was present in these lesions. The second type of graft arteriosclerosis consisted of complex atheromatous lesions, containing myointimal cells, lipid-laden foam cells, fragmented internal elastic laminae, and calcifications. 15-LO immunostaining of myointimal cells, lipid-laden foam cells, and endothelial cells was consistently present in these atheromatous lesions. The majority of the myointimal and foam cells positive for 15-LO were recognized by antisera to α-smooth muscle actin; the others were identified as macrophages. The results indicate that 15-LO expression is present in endothelial, myointimal, and foam cells in complex atheromatous lesions of TCAD, and suggest that 15-LO may play a role in the pathogenesis of this form of the disease.

Original languageEnglish (US)
Pages (from-to)340-348
Number of pages9
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume15
Issue number3
StatePublished - 1995
Externally publishedYes

Fingerprint

Arachidonate 15-Lipoxygenase
Coronary Artery Disease
Transplants
Foam Cells
Lipids
Coronary Vessels
Endothelial Cells
Macrophages
Tunica Intima
Linoleic Acids
Rabbits
Avidin
Arteriosclerosis
Heart Transplantation
Biotin
LDL Lipoproteins
Arachidonic Acid
Pulmonary Artery
Smooth Muscle Myocytes
Smooth Muscle

Keywords

  • 15-lipoxygenase
  • coronary artery disease
  • graft arteriosclerosis
  • lipid oxidation
  • transplantation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Immunohistochemical demonstration of 15-lipoxygenase in transplant coronary artery disease. / Ravalli, S.; Marboe, C. C.; D'Agati, V. D.; Michler, Robert E.; Sigal, E.; Cannon, P. J.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 15, No. 3, 1995, p. 340-348.

Research output: Contribution to journalArticle

Ravalli, S. ; Marboe, C. C. ; D'Agati, V. D. ; Michler, Robert E. ; Sigal, E. ; Cannon, P. J. / Immunohistochemical demonstration of 15-lipoxygenase in transplant coronary artery disease. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 1995 ; Vol. 15, No. 3. pp. 340-348.
@article{862e7adbe4954e37ac084b9c356c42c2,
title = "Immunohistochemical demonstration of 15-lipoxygenase in transplant coronary artery disease",
abstract = "15-Lipoxygenase (15-LO) catalyzes the oxygenation of arachidonic acid linoleic acids and has been implicated in the oxidative modification of low-density lipoproteins (LDL). 15-LO mRNA and protein have previously been demonstrated in macrophages of rabbit and human atherosclerotic lesions. The purpose of this study was to investigate whether 15-LO is also present in the accelerated form of coronary artery disease that can complicate cardiac transplantation (TCAD). Immunohistochemical analysis of coronary arteries with TCAD was carried out by using a rabbit polyclonal antibody raised against human recombinant 15-LO and an avidin-biotin-immunoperoxidase system. Normal coronary and pulmonary arteries showed no immunostaining for 15-LO. Two different types of TCAD were observed. One type consisted of concentric intimal proliferation of smooth muscle cells, without lipid or calcium deposits. No immunoreactivity for 15-LO was present in these lesions. The second type of graft arteriosclerosis consisted of complex atheromatous lesions, containing myointimal cells, lipid-laden foam cells, fragmented internal elastic laminae, and calcifications. 15-LO immunostaining of myointimal cells, lipid-laden foam cells, and endothelial cells was consistently present in these atheromatous lesions. The majority of the myointimal and foam cells positive for 15-LO were recognized by antisera to α-smooth muscle actin; the others were identified as macrophages. The results indicate that 15-LO expression is present in endothelial, myointimal, and foam cells in complex atheromatous lesions of TCAD, and suggest that 15-LO may play a role in the pathogenesis of this form of the disease.",
keywords = "15-lipoxygenase, coronary artery disease, graft arteriosclerosis, lipid oxidation, transplantation",
author = "S. Ravalli and Marboe, {C. C.} and D'Agati, {V. D.} and Michler, {Robert E.} and E. Sigal and Cannon, {P. J.}",
year = "1995",
language = "English (US)",
volume = "15",
pages = "340--348",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Immunohistochemical demonstration of 15-lipoxygenase in transplant coronary artery disease

AU - Ravalli, S.

AU - Marboe, C. C.

AU - D'Agati, V. D.

AU - Michler, Robert E.

AU - Sigal, E.

AU - Cannon, P. J.

PY - 1995

Y1 - 1995

N2 - 15-Lipoxygenase (15-LO) catalyzes the oxygenation of arachidonic acid linoleic acids and has been implicated in the oxidative modification of low-density lipoproteins (LDL). 15-LO mRNA and protein have previously been demonstrated in macrophages of rabbit and human atherosclerotic lesions. The purpose of this study was to investigate whether 15-LO is also present in the accelerated form of coronary artery disease that can complicate cardiac transplantation (TCAD). Immunohistochemical analysis of coronary arteries with TCAD was carried out by using a rabbit polyclonal antibody raised against human recombinant 15-LO and an avidin-biotin-immunoperoxidase system. Normal coronary and pulmonary arteries showed no immunostaining for 15-LO. Two different types of TCAD were observed. One type consisted of concentric intimal proliferation of smooth muscle cells, without lipid or calcium deposits. No immunoreactivity for 15-LO was present in these lesions. The second type of graft arteriosclerosis consisted of complex atheromatous lesions, containing myointimal cells, lipid-laden foam cells, fragmented internal elastic laminae, and calcifications. 15-LO immunostaining of myointimal cells, lipid-laden foam cells, and endothelial cells was consistently present in these atheromatous lesions. The majority of the myointimal and foam cells positive for 15-LO were recognized by antisera to α-smooth muscle actin; the others were identified as macrophages. The results indicate that 15-LO expression is present in endothelial, myointimal, and foam cells in complex atheromatous lesions of TCAD, and suggest that 15-LO may play a role in the pathogenesis of this form of the disease.

AB - 15-Lipoxygenase (15-LO) catalyzes the oxygenation of arachidonic acid linoleic acids and has been implicated in the oxidative modification of low-density lipoproteins (LDL). 15-LO mRNA and protein have previously been demonstrated in macrophages of rabbit and human atherosclerotic lesions. The purpose of this study was to investigate whether 15-LO is also present in the accelerated form of coronary artery disease that can complicate cardiac transplantation (TCAD). Immunohistochemical analysis of coronary arteries with TCAD was carried out by using a rabbit polyclonal antibody raised against human recombinant 15-LO and an avidin-biotin-immunoperoxidase system. Normal coronary and pulmonary arteries showed no immunostaining for 15-LO. Two different types of TCAD were observed. One type consisted of concentric intimal proliferation of smooth muscle cells, without lipid or calcium deposits. No immunoreactivity for 15-LO was present in these lesions. The second type of graft arteriosclerosis consisted of complex atheromatous lesions, containing myointimal cells, lipid-laden foam cells, fragmented internal elastic laminae, and calcifications. 15-LO immunostaining of myointimal cells, lipid-laden foam cells, and endothelial cells was consistently present in these atheromatous lesions. The majority of the myointimal and foam cells positive for 15-LO were recognized by antisera to α-smooth muscle actin; the others were identified as macrophages. The results indicate that 15-LO expression is present in endothelial, myointimal, and foam cells in complex atheromatous lesions of TCAD, and suggest that 15-LO may play a role in the pathogenesis of this form of the disease.

KW - 15-lipoxygenase

KW - coronary artery disease

KW - graft arteriosclerosis

KW - lipid oxidation

KW - transplantation

UR - http://www.scopus.com/inward/record.url?scp=0028936955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028936955&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 340

EP - 348

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 3

ER -